SCHEMBL23916028

SCHEMBL23916028

Cc1cc(-c2ccc(N)cc2-c2nnn[nH]2)ccn1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CCNC P24863 2/20 0.38
CDK8 P49336 2/20 0.38
DYRK1A Q13627 3/20 0.36
NFATC1 O95644 1/20 0.36
MAP4K4 O95819 3/20 0.35
CDC7 O00311 1/20 0.34
ROCK2 O75116 1/20 0.34
CDK2 P24941 1/20 0.34
GSK3B P49841 1/20 0.34
CLK4 Q9HAZ1 1/20 0.34
MKNK2 Q9HBH9 1/20 0.34
IRAK4 Q9NWZ3 1/20 0.34
MTOR P42345 1/20 0.34
PIK3CB P42338 1/20 0.33
LRRK2 Q5S007 1/20 0.33
PIM1 P11309 1/20 0.33
DYRK2 Q92630 1/20 0.33
DYRK1B Q9Y463 1/20 0.33
PDE3B Q13370 1/20 0.32
PDE3A Q14432 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23916008 0.84 ADORA2B (0.42) DYRK1ANFATC1MAP4K4
SCHEMBL20329239 0.84 DYRK1A (0.39) DYRK1ALRRK2PDE3BPDE3A
SCHEMBL23916490 0.84 MTOR (0.37) MAP4K4MTOR
SCHEMBL23916420 0.82 HPGDS (0.36) DYRK1ACDK2PIK3CBPDE3BPDE3A
SCHEMBL23915989 0.81 PDE3B (0.31) MAP4K4PDE3BPDE3A
SCHEMBL23916021 0.81 AAK1 (0.33) ROCK2
SCHEMBL23916460 0.81 PARP15 (0.39) DYRK1AMAP4K4LRRK2
SCHEMBL23910007 0.81 CCNC (0.34) CCNCCDK8DYRK1ANFATC1MAP4K4
SCHEMBL14217428 0.80 ALDH1A1 (0.34) DYRK1AROCK2
SCHEMBL20329240 0.76 KDM4E (0.39) GSK3BCLK4PIM1DYRK1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210317092-A1 TETRAZOLE CONTAINING COMPOUNDS BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2021-10-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210317092-A1 TETRAZOLE CONTAINING COMPOUNDS TSLP, IL5, TRPA1 CCNC 3624/4885CDK8 2945/4885DYRK1A 2200/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.